Dr. Srikanth Kakumanu earned his MS, PhD from Department of Biomedical Engineering and Biotechnology at University of Massachusetts in 2010. His major focus from last 12 years is around Drug delivery using Nanotechnology, prior to that he performed research in the area of hematopoietic stem cells.
He is involved with both biotechnology and pharmaceutical fields for last 15 years. He is author of 189 publications and holds 5 patents. His interests are in R&D and platform technology.